1.
Clinical Psychopharmacology and Neuroscience
; : 508-509, 2018.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-718207
2.
J Neuroimmunol
; 240-241: 137-41, 2011 Dec 15.
Article
in English
| MEDLINE
| ID: mdl-22001684
ABSTRACT
Relapsing-remitting multiple sclerosis (RRMS), secondary progressive (SP)MS and primary progressive (PP)MS patients showed higher percentages of circulating CD8+CD56-perforin+ T cells than controls whereas only relapsing RRMS and PPMS patients showed higher perforin expression in CD8+CD56- T cells than controls. MS patients with EDSS ≥3 showed higher percentage of CD8+CD56-perforin+ T cells than patients with EDSS <3 and controls whereas patients with EDSS <3 showed higher percentage of this T cell subpopulation than controls. Our data show that MS is characterized by a dysregulation of CD8+CD56-perforin+ T cells that may play a role in the development of disability.
